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Abstract
Financing incidence analysis (FIA) assesses how the burden of health financing is distributed in
relation to household ability to pay (ATP). In a progressive financing system, poorer households
contribute a smaller proportion of their ATP to finance health services compared to richer house-
holds. A system is regressive when the poor contribute proportionately more. Equitable health
financing is often associated with progressivity. To conduct a comprehensive FIA, detailed house-
hold survey data containing reliable information on both a cardinal measure of household ATP and
variables for extracting contributions to health services via taxes, health insurance and out-of-
pocket (OOP) payments are required. Further, data on health financing mix are needed to assess
overall FIA. Two major approaches to conducting FIA described in this article include the structural
progressivity approach that assesses how the share of ATP (e.g. income) spent on health services
varies by quantiles, and the effective progressivity approach that uses indices of progressivity such
as the Kakwani index. This article provides some detailed practical steps for analysts to conduct
FIA. This includes the data requirements, data sources, how to extract or estimate health payments
from survey data and the methods for assessing FIA. It also discusses data deficiencies that are
common in many low- and middle-income countries (LMICs). The results of FIA are useful in
designing policies to achieve an equitable health system.
Keywords: Financing incidence analysis, progressivity, regressivity, health financing, ability-to-pay, methodology
Key Messages
• Financing incidence analysis (FIA) requires the availability of comprehensive household survey data that contain infor-
mation on a cardinal measure of ability to pay (ATP) such as income or expenditure and relevant variables to extract or
estimate household contributions via various health financing mechanisms
• Progressive health financing is usually preferred to regressive health financing because it places less burden on poorer
households relative to richer households. Researchers should be cautious however as progressive health financing can
sometimes result from unfair treatment of the poor.
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Introduction
Fairness in a country’s health financing system is a key dimension to
assess a health system’s performance (World Health Organization,
2000). In fact, it has been noted that equity or fairness in health
financing, where households contribute to the health system accord-
ing to their ability to pay (ATP), should form an important health
system goal to promote universal health coverage (UHC) (Kutzin,
2013). Financing incidence analysis (FIA) is a way to assess how
equitable a health financing system is. In general, an equitable health
system requires inter alia equity in health care financing and utiliz-
ation, defined respectively as payment for health services according
to ATP and the receipt of health service benefits according to need
(Mills et al. 2012).
This article, which focuses on FIA complements an earlier article
in this series which explains how to do (or not to do) a benefit inci-
dence analysis (BIA) (McIntyre and Ataguba 2011). It is written to
provide an introductory and detailed guide to FIA that will be acces-
sible to different groups including researchers, data analysts and
practitioners.
The rest of the article is structured as follows. The next section
provides an overview of FIA. This is followed by an introduction to
the different ways of assessing FIA. Thereafter, a detailed overview
of how to conduct an empirical assessment of FIA is presented
including worked examples. The last section provides a brief discus-
sion of issues including the strengths and weaknesses of the
approach.
What is FIA?
FIA is an analytical method used for comprehensively evaluating
equity in health financing including the equity impact of UHC
reforms relating to the health financing system. Some authors refer
to FIA as progressivity analysis or just the analysis of equity in
health care financing. FIA assesses the distribution of the ‘burden’ of
health financing in a population stratified by household ATP and
sometimes the extent to which this burden affects the underlying dis-
tribution of ATP (Wagstaff and van Doorslaer 1993, 1997). Such
assessments could also be conducted over time to assess progress
towards a more equitable health financing system (Ataguba, 2016).
Essentially, FIA assesses who pays for health care and how payments
are distributed according to socioeconomic status or a measure of
ATP. Results from FIA indicate vertical equity when households or
groups with different ATP contribute appropriately different
amounts for health care (Culyer and Wagstaff 1993; Wagstaff and
van Doorslaer 2000; Cisse´ et al. 2007). Unfortunately, there is no
predetermined extent of differential treatments that analysts can
describe as vertically equitable (Mooney, 1996) as this is an issue of
normative judgement and such decisions will be different for differ-
ent societies.
A progressive health-care payment occurs when such payment as
a proportion of ATP is an increasing function of ATP (i.e. when the
rich contribute a relatively higher proportion of their ATP in financ-
ing health services than the poor). Regressive health-care payments
are the opposite of progressive payments and they are normally
regarded as inequitable (Wagstaff, 2002) and unfair. Stated differ-
ently, FIA is based on assessing deviations from proportionality, a
case where every household pays the same share of ATP towards
health financing (Kakwani, 1977).
Because of the centrality of FIA for health sector reforms, there
is an increasing demand for FIA among researchers, health managers
and practitioners in many low- and middle-income countries
(LMICs) (Asante et al. 2016). A complementary analysis, BIA, is
also used to assess the pro-poorness of the health-care delivery sys-
tem and the extent to which those that need health services are bene-
fiting according to need (McIntyre and Ataguba 2011; Wagstaff,
2012). Together, these analyses (FIA and BIA), which have been
combined in recent research (Akazili et al. 2012; Ataguba and
McIntyre 2012; Mtei et al. 2012; Kwesiga et al. 2015; Asante et al.
2017), provide an overall picture of how the health financing system
of a country is performing on equity grounds and progressing
towards UHC. For a holistic picture of equity, practitioners are
encouraged to assess both distributions.
Different ways to assessing FIA
Countries vary in their health-care financing mixes. FIA can be con-
ducted for individual health-care financing mechanisms and/or on
the entire health financing system, comprising all the health-care
financing mechanisms. Conceptual basis and empirical methods for
FIA originate mainly within the economics discipline. We discuss
the methods in turn with emphasis on the widely used approaches.
Structural progressivity
This is the simplest and perhaps one of the earliest ways to crudely
assess progressivity. It makes no reference to the distribution of ATP
(Khetan and Poddar 1976; Schueler and Terry 1983). Empirically,
for health services, it has been assessed by looking at how payments
for health care as a share of ATP vary by quantiles of ATP (Uga´ and
Santos 2007; Prakongsai et al. 2009; Akazili et al. 2011; Mills et al.
2012). An example of structural progressivity is illustrated in
Figure 2. First, households are categorized into quantiles of ATP
(e.g. tertiles, quartiles, quintiles, deciles, etc.) to assess progressivity.
The share of ATP that each quantile spent on health care via each
mechanism (for instance general tax, out-of-pocket (OOP) pay-
ments, social insurance contribution, etc.) is computed. Next, an
examination of how the ratios or average payment shares (i.e. the
analogue of average tax rate) vary across quantiles is used to assess
progressivity. If the ratios are increasing with the quantiles of ATP,
that health-care financing mechanism is considered progressive. It is
regressive if the reverse is the case. If the ratios remain constant for
all quantiles, health-care financing is considered as proportional.
While the assessment of structural progressivity has an appeal, it has
some limitations especially as it has been applied in health financing.
For example, if quantiles are used, progressivity is not sensitive to
variations that may occur close to the cut-off points for each quan-
tile. Also, it does not show a holistic picture of how health-care pay-
ment to ATP ratio varies across the entire distribution of ATP. More
importantly for policy, the exact extent of progressivity may not be
obtained simply by looking at these ratios. In fact, in some situations
it could be difficult to distinguish which mechanism is more progres-
sive or less regressive than the other. Although it is not used in
empirical assessment of progressivity in health financing, some
degree of progressivity may be obtained using the structural progres-
sivity approach. This is simply the slope coefficient of the curve that
plots the relationship between each household’s average payment
share and ATP where households are ranked by increasing ATP
(Schueler and Terry 1983).
Effective progressivity
The pioneering effort in defining effective progressivity in the
broader economics literature is traced to the work of Musgrave and
Thin (1948). Subsequently, several indices have been proposed to
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assess progressivity mainly within the context of taxes (see e.g.
Kakwani, 1977; Suits, 1977; Slesnick, 1986). These indices are often
referred to as measures of effective progressivity as opposed to struc-
tural progressivity.
The most popular of these indices that will be considered in this
article is the Kakwani index (Kakwani, 1977). This index is based on
two underlying curves —the Lorenz curve of ATP distribution and the
concentration curve of health-care payments (see Figure 1). A progres-
sive health financing mechanism or system, as shown in Figure 1a
occurs when the Lorenz curve of pre-payment ATP lies above the con-
centration curve of health-care payments and the extent of progressiv-
ity, that is the Kakwani index is defined as two times the shaded area.
The relationship shown in Figure 1b is regressive. Proportional financ-
ing where the Kakwani index is theoretically zero corresponds to
a situation where the two curves lie on each other. In some cases,
the Kakwani index may be zero when the two curves cross each
other.
In an empirical analysis, the Kakwani index is computed from
the Gini index and the concentration index that are associated
with the Lorenz curve and the concentration curve, respectively
(Kakwani, 1977; Kakwani et al. 1997) (see Table 1).
The Kakwani index is a summary measure. As such, it is some-
times complemented with statistical dominance tests using statistical
software to ascertain whether progressivity or regressivity is consis-
tent along the entire distribution of ATP (i.e. whether the Lorenz
and concentration curves cross) and/or which financing mechanism
is more progressive or less regressive than the other (i.e. whether
concentration indices do not cross) (Bishop et al. 1994; Davidson
and Duclos 1997). Dominance tests can also be performed to assess
progressivity over time (Ataguba, 2016). Many empirical analyses
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Figure 1. An illustration of a progressive and regressive health financing.
Note: ATP ¼ Ability to pay.
Source: Authors’ illustration
Table 1. A summary of the selected indices for assessing equity in health financing
Index type Description
The Gini index This is obtained from the Lorenz curve that plots the cumulative percentage of ATP (e.g. income) against the cumulative
percentage of the population, usually ranked by ATP. The Gini index corresponds to the ratio of the area between the
line of equality (i.e. the 45 line) and the Lorenz curve of ATP to the area between the line of equality and the line of per-
fect inequality.
The Gini index ranges from 0 (a case of perfect equality in the distribution of ATP) toþ 1 (a case of perfect inequality in
the distribution of ATP).
The closer the value of the Gini index is toþ 1, the less unequal is the distribution of ATP while the closer the Gini index is
to 0, the more equal is the distribution of ATP.
The concentration
index
This is obtained from the concentration curve that plots the cumulative percentage of health-care payments (e.g. private
health insurance) against the cumulative percentage of the population, ranked by ATP (see Figure 1). The concentration
index corresponds to twice the area between the line of equality (i.e. the 45 line) and the concentration curve of health-
care payments.
The concentration index ranges from 1.0 (a situation where the poorest household contributes all health-care payments)
toþ 1.0 (where all health-care payments are made by the richest household).
A negative concentration index means that the concentration curve of health-care payments lies above the line of equality
while a positive value means that the concentration curve lies below the line of equality.
A convenient Stata ado-file (-conindex-) can be used to estimate this index (O’Donnell et al. 2016).
The Kakwani index For any health-care financing mechanism j, the Kakwani index of progressivity (pj) is obtained as the difference between
the concentration index of health-care payments (Cj) and the Gini index of ATP inequality (G). That is, pj ¼ Cj G.
The Kakwani index corresponds to twice the area between the Lorenz curve of ATP and the concentration curve of
health-care payments.
Its values lie between 2 (the most regressive financing) and þ1 (the most progressive financing). Theoretically, the case of
proportional financing corresponds to pj ¼ 0.
A positive value (pj > 0) means that the health financing mechanism j is progressive as richer households contribute propor-
tionately more than their share of ATP. A negative value (pj < 0) implies that the health financing mechanism is regres-
sive as the proportion of health-care payments contributed by poorer households is greater than their share of ATP.
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have used the multiple comparison approach (MCA)1 for the domi-
nance tests (O’Donnell et al. 2008b).
Computing the Gini, concentration and Kakwani indices
The Gini and concentration indices (IG;C), hence the Kakwani index,
can be computed using various formulas. One of the simplest ways
to compute the Gini or concentration index is using the ‘convenient
covariance’ formulation (i.e. in terms of the covariance between the
relevant variable and the rank of pre-payment ATP) (Kakwani,
1980; Lerman and Yitzhaki 1989). This is shown as:
IG;C ¼ 2 covðy; rÞ=ly
where y is either pre-payment ATP (for the Gini index) or health-
care payments (for the concentration index), r is the rank of ATP
and ly is the mean of y. Another common approach used to com-
pute IG;C is the convenient regression approach (Kakwani et al.
1997). A collection of Stata commands to compute IG;C and the
Kakwani index can be found in O’Donnell et al. (2008b). Also, these
indices can be estimated using the World Bank ADePT software
(www.worldbank.org/adept). Due to space limitation, we did not
provide all the methods for computing these indices but refer readers
to Duclos and Araar (2006) and O’Donnell et al. (2008b) for a
detailed exposition of these methods. A user-friendly Stata ado-file
(-fia-), which produces results for structural progressivity and the
Kakwani index, has been written. This can be made available upon
request.
Empirical assessment of FIA
Some empirical analyses have been conducted using the structural
progressivity approach (Uga´ and Santos 2007; Akazili et al. 2011;
Mills et al. 2012) and the effective progressivity approach (via the
Kakwani index) (Wagstaff and van Doorslaer 1997; Wagstaff et al.
1999). Some authors present results using both approaches (see
Asante et al. 2016). Detailed steps and procedures for assessing FIA
are presented in Table 2. The table also provides a summary of the
data requirements and issues that analysts need to take note of when
conducting FIA.
Three key issues that emerge from Table 2 that need further
explanation include (i) the process of extracting or estimating the
various health-care payment variables including the assumptions
about who bears the final burden of such payments (Table 3 con-
tains details of the various assumptions that researchers have used to
extract health payments from household surveys), (ii) the different
measures of household ATP for FIA (see Box 1) and (iii) the compu-
tation of per capita or per adult equivalent health-care payments
and ATP (e.g. income or expenditure) (see Box 2).
In what follows, examples of structural and effective progressiv-
ity are presented using South Africa as the case study.
Assessing progressivity of health financing in South
Africa
South Africa, a sub-Saharan African country with reliable data sour-
ces, finances health services via three broad mechanisms—general
taxes (38% of total health finances), private health insurance
(50%) and OOP payments (12%) (Ataguba and McIntyre
2018).
Data sourcing, cleaning and extraction
The nationally representative Income and Expenditure Survey data-
set for 2011/12 was used to extract household contributions to
taxes, OOP payments and private health insurance (Ataguba and
McIntyre 2018). Because not all tax revenue is allocated to the
health sector, only about 11% of total tax extracted was considered
for analysis (see Table 2). ATP was measured using per adult equiva-
lent consumption expenditure. In terms of the final burden of each
financing mechanism, direct taxes are borne by the legal tax payer,
indirect taxes by consumers, private health insurance by the insured
household or individual and OOP payments by the users of health
services. Due to space limitation, we refer the reader to Ataguba and
McIntyre (2018) for details on how contributions for each health
financing mechanism were extracted for each household.
Estimating the progressivity of each health financing mechanism
Structural progressivity was assessed by categorizing households
into quintiles of ATP. Then, the average fraction of ATP that house-
holds in each quintile spends on each health financing mechanism
was computed.
The results shown in Figure 2 indicate that OOP spending and
indirect taxes are regressive. The richest quintile (i.e. the top 20% of
the population in terms of ATP) pay less as a proportion of their
income than the poorest 20% of the population. Direct taxes, total
taxes and private health insurance are progressive because the bot-
tom 20% of the population contributes less as a proportion of their
ATP compared to the higher quintiles.
Effective progressivity was assessed using the Kakwani index of
progressivity. The conclusions based on the results shown in Table 4
are similar to those shown in Figure 2. Indirect taxes and OOP pay-
ments are regressive (negative Kakwani indices) while direct taxes,
total taxes and private health insurance are progressive (positive
Kakwani indices). These results are also confirmed by the test of
statistical dominance.
Estimating overall progressivity of health financing
Overall, health-care financing is progressive in South Africa. This
is the case for both the structural and effective progressivity
approaches. As shown in Figure 2, the bottom 20% of the popula-
tion spends about 5% of their ATP financing health services com-
pared to about 15% spent by the richest quintile. Also in Table 4,
the Kakwani index of overall health financing in South Africa was
estimated at 0.101 [i.e. (0.38 * 0.0824)þ (0.12 * (0.0289))þ
(0.50 * 0.1417)¼0.10]. Ataguba and McIntyre (2018) exercise cau-
tion in interpreting these progressivity results since the major driver
(private health insurance) covers <20% of the South African popu-
lation who are mainly the rich. In fact, Ataguba and McIntyre
(2018) showed that contributions to private health insurance were
regressive among those that are insured.
Interpreting results for policy
Although the share of OOP payments in total health financing in
South Africa is low, the regressivity of this means that there is a
need to avoid increasing this burden either through increased
co-payments or user fees. In South Africa, general taxes contribute
significantly to total health financing and they are progressive.
Thus, an increased reliance on especially direct taxes will yield a
progressive total health financing, all things being equal. Recently,
the South African government is in the process of reforming the
health sector. Therefore, these findings will provide baseline infor-
mation in terms of useful progressive mechanisms for financing their
national health system.
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Table 2. Detailed steps and processes involved in conducting FIA
Step 1: Data sourcing, cleaning and extraction
Activity • Extract or estimate each household’s total contribution to each health financing mechanism (e.g. OOP spending, direct taxes,
indirect taxes, earmarked taxes, private and social health insurance contributions, etc.). Preferably, this should be expressed as
annual contributions.
• Compute each household’s income or expenditure (i.e. the household pre-payment income)—a measure of ATP. This should be
gross of all health-care payments. It should also be annualized as some items like frequent purchases have a short recall period
while non-frequent purchases have longer recall periods.
• Estimate household size (or an adult equivalent household size that accounts for the composition of the household) using the
same dataset.
Requirement • Detailed survey data (usually nationally representative) that contain information on ATP (e.g. income or expenditure) and
other relevant data for assessing health payments. Typical examples of datasets for national analysis include the Living
Standards Measurement Surveys, Living Conditions Monitoring Surveys, Income and Expenditure Surveys, Household Budget
Surveys, Consumer Expenditure Surveys, Survey of Household Spending and Health Expenditure & Utilization surveys.
• Typical sources of data include the national statistical authority, international data repositories or databanks and research
institutions.
• Different parameter values are required for estimating adult equivalent household size depending on the adult equivalent scale
that is selected. This is explained in Box 2.
Remark • The measure of ATP and all health-care payments should be extracted from the same dataset. They should be expressed in the
same time frequency (preferably annual).
• In the case where health expenditures are not directly reported but are estimated (e.g. many indirect taxes), things like the struc-
ture of tax rates, tax brackets as well as any rebate or tax exemptions are necessary. This information is usually contained in
government reports and published papers. Also, reliable assumptions about who bears the final burden of each payment are
needed to extract them (see Table 3).
• In some cases, data on health payments may be limited in household surveys (Borghi et al. 2009) as these surveys were not
designed primarily for health expenditure. It is important to note limitations in these data, if any, for FIA (see the discussion
section).
• Where a household does not contribute to a specific health financing mechanism, their payment should be recorded as zero. For
example, if household A did not pay OOP for health services, OOP spending for this household should be recorded as zero and
not missing. This has implications for estimation in many software including Stata.
• In some cases (especially non-earmarked taxes), not all the contributions extracted or estimated are allocated to the health sec-
tor. Thus, only the proportion that is allocated to the health sector should be considered. For example, if only 15% of total
non-earmarked tax revenue is allocated to the health sector, tax estimates need to be scaled by 15%.
• Where nationally representative household data are not available, it is possible for researchers to commission primary surveys
for FIA (Borghi et al. 2009). However, this process can be very costly. Alternatively, analysts can lobby for relevant questions
to be incorporated into already existing surveys.
Step 2: Estimating the progressivity of each health-care financing mechanism
Activity • Estimate the progressivity of each health-care financing mechanism after adjusting for a measure of household size (or adult
equivalent household size) either using the structural or effective progressivity approach.
• The structural progressivity approach involves categorizing households into quantiles (e.g. quartiles or quintiles) of pre-pay-
ment ATP. For each qunatile, an estimate of health-care payment as a fraction of ATP (i.e. average payment share) is computed
by applying the appropriate household weights.
• The effective progressivity approach (e.g. using the Kakwani index) involves applying a computer routine (e.g. -fia-) to obtain
the index.
Requirement • Extracted or estimated contributions for all the relevant health financing mechanisms by all households. These are used to com-
pute progressivity.
• Each household’s estimated ATP (i.e. income or expenditure) before any health-care payment from the same nationally repre-
sentative survey data.
• The dataset should contain relevant variables that show the detailed sample design of the dataset. This should include the pri-
mary sampling unit, the strata variable and household weight necessary to make estimates reflect national figures.
Remark • All health-care payments (including taxes, private or social insurance contributions, or OOP spending) estimated at the house-
hold level should be divided by a measure of household size (e.g. actual number of people in that household or an estimated
adult equivalent household size). The appropriate household weight should be applied when estimating progressivity to obtain
estimates that are reflective of the entire country or region of reference.
• In the case of structural progressivity assessments where some form of average payment rates are computed, it is necessary to
adjust all relevant variables to reflect national aggregates. For example, comparing the extracted direct tax estimates with that
reported by the national tax authority and adjusting the tax variable accordingly (see e.g. Borghi et al. 2009).
Step 3: Assessing overall progressivity in health-care financing
Activity • Structural progressivity: this can be assessed in two ways: (1) adding up all the extracted health-care payment variables for
each household and computing the average payment shares by quantiles or (2) adding up the average payment share of each
health-care financing mechanism by quantiles.
• Effective progressivity: the additively separable property of the Kakwani index allows for the weighting of the estimated index
of each mechanism by the share of that financing mechanism in total health financing. This is used to obtain overall progressiv-
ity for that country.
(continued)
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Discussion
FIA remains an important analysis for countries wanting to assess
how equitable its health financing system is. Such analysis is useful
for assessing how each health financing mechanism deviates from
proportionality and for assessing how progressive or regressive an
entire health financing system is. Regressive financing is usually
considered as unfair as it places a heavier burden on the poor.
Although progressive health financing is preferred, such a result
needs to be critically examined within the context of the health
financing arrangements in a country. This includes a careful and
thorough examination of the way health funds are used to pur-
chase health services. For example, it may be the case that OOP
spending comprises the bulk of total health financing and it is esti-
mated as a progressive financing mechanism. Such a progressive
relationship may result from a case where the poor are unable to
pay and use health services. It may also be primarily because the
poor are exempted from paying fees. The interpretation given to
either of these cases is different. If OOP spending is progressive
because the poor are exempted from paying for health services and
there are no other access barriers, such progressivity may be
Table 2 (continued)
Step 1: Data sourcing, cleaning and extraction
Requirement • Structural progressivity: (1) estimated or extracted health-care payments for all financing mechanisms for each quantile and (2)
the computed average payment shares by quantiles for each financing mechanism.
• Effective progressivity: In addition to the Kakwani indices, the share of each health financing mechanism in total health financ-
ing is needed. Such information can be obtained from the country’s National Health Accounts (NHA), published papers, the
Ministry of Health or Finance or any other relevant government institution.
Remark • Ideally, the health financing mix (e.g. a1, a2 and a3) should be obtained from NHA data. An earlier paper in this series shows
the various uses of the NHA (Price et al. 2016). Generally, for countries where data are available, NHA country tables can be
found at http://www.who.int/health-accounts/en. Where NHA data are not available, public expenditure reviews and reports
that collect information on household health care and other expenditure can be used. Even published empirical research on
health financing mix can be used.
• Using the Kakwani index, it is possible that the extracted financing mix accounts for less than 100% of total health financing. So, there
are suggested ways to adjust overall health financing based on assumptions about how the omitted financing mechanism is distributed
(O’Donnell et al. 2008b). For example, if the omitted financing mechanism is private health insurance and by assumption it is distrib-
uted in a similar way to personal income tax, the Kakwani index of personal income tax is assumed for private health insurance.
Step 4: Interpreting results for policy
Activity • Interpret the results to assist in policy formulation and/or implementation.
Requirement • An understanding of the country’s health financing challenges.
Remark • Sensitivity analysis may be conducted to assess the impact of changing the health financing mix and the structure of health
financing in the country. For example, what will happen to overall progressivity if the country’s reliance on OOP spending
drops by 20%? This can be answered using the Kakwani index because pTotal ¼ a1p1 þ a2p2 þ a3p3 in the case where there are
three financing mechanisms.
Table 3. Extracting the various health-care payment variables
Health financing
mechanism
Estimation process
OOP spending The final burden of OOP spending rests on the household that pays. Importantly, such payments include all direct payments
made to a health service provider usually at the point of using such health service (Rannan-Eliya 2010). In some surveys,
they are disaggregated while in others they are reported as an aggregate figure. While disaggregated OOP data may be more
comprehensive (Lu et al. 2009), it is important to ensure that OOP spending does not include any portion reimbursed by any
third party. A household’s OOP financing of another household’s OOP costs may not be included in the recipient’s OOP
spending.
Private and social
health insurance
contributions
Generally, the final burden of private health insurance (whether it is financed by the employer and/or employee) is, by assump-
tion, borne by the household. The same is usually the case for social health insurance contributions on behalf of the
employee.
Taxes For taxes, except for personal income tax, the final burden may be shifted away from the entity that was initially levied.
A detailed understanding of this process within each country is relevant for extracting and estimating household contribu-
tions to taxes. Generally, however, indirect taxes tend to be shifted forward onto consumers/households. The tax rates of
these indirect taxes are applied to household reported expenditures to extract household tax payments.
Where a tax is earmarked, it is extracted accordingly depending on the type of tax. For example, an earmarked tax on income
from gambling will be extracted by applying the tax rate on reported income from gambling. In this case, the final burden
rests on the gambler.
One of the most challenging taxes to allocate is corporate income tax and some researchers either assume that the burden
is similar to personal income tax (Wagstaff and van Doorslaer 1992) or shared between consumers and capital owners
(Ataguba and McIntyre 2012).
Readers interested in detailed examples of how to extract or compute the contributions through each health financing mecha-
nism for every household can refer to the studies in Ghana (Akazili et al. 2011), South Africa (Ataguba and McIntyre 2012),
Tanzania (Mtei et al. 2012) and Fiji (Asante et al. 2016).
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regarded as ‘fair’. This is opposed to the case where a progressive
OOP spending is primarily because the poor are unable to afford
and/or use health services. Also, if private voluntary health insur-
ance constitutes a large share of total financing and it is
progressive, it may not mean that the entire health financing sys-
tem is equitable per se as discussed in Ataguba and McIntyre
(2012).
Box 1: Different measures of household ATP for FIA
The measurement of ATP is a key element of FIA. There
has been widespread debate about the most appropriate
measure of ATP ranging from permanent income to con-
sumption expenditure (Buehler, 1945; Wagstaff and van
Doorslaer 1993; Miller, 2005). In general, there are a few
options for estimating ATP for FIA. In developed coun-
tries, apart from a few studies that use expenditure
(Lancaster et al. 1999), income is often the preferred
measure. In developing countries, however, expenditure
or consumption is usually the preferred measure
(Younger et al. 1999; Sahn and Stifel 2003; O’Donnell
et al. 2008a,b). The use of expenditure in many develop-
ing countries is attributed to the difficulties inherent in
measuring income, ‘the seasonal variability in such earn-
ings, and the large shares of income . . . from self-
employment both in and outside of agriculture’ (Sahn
and Stifel 2003, p. 464) that may not be recorded by
households as income (O’Donnell et al. 2008b). The large
informal sector in developing countries also contributes
to the unreliability of income. Income may also be con-
cealed to evade taxation (Lancaster et al. 1999). A more
robust measure of ATP is household consumption
expenditure that measures long-term welfare level rather
than current income (Blundell and Preston 1995). This
includes the value of non-market consumptions in addi-
tion to household frequent and non-frequent purchases.
In empirical studies, it is defined as the ‘[f]inal use of
goods and services, excluding the intermediate use of
some goods and services in the production of others’
(O’Donnell et al. 2008b, p. 70). Thus, depending on the
availability of indicators for ATP, only cardinal measures
of ATP rather than ordinal measures are used for assess-
ing progressivity or FIA.
Box 2: Computing per capita or per adult equivalent
health-care payments and ATP
Per adult equivalent household size can be computed in
many ways. One of the most popular ways is to define
an adult equivalent scale (ES) as (Deaton, 1997):
ES ¼ ðAþ aCÞh
where A is the number of adults in the household, C is
the number of children, a is a measure of the relative
weight accorded to children and h is a measure of
economies of scale. If the value of a gets closer to 1,
then the consumption of a child is assumed to be almost
equivalent to that of an adult. If the value of h gets closer
to 1 it signifies the absence of economies of scale such
that larger households, on average, do not live more
cheaply than smaller households. When a ¼ h ¼ 1, ES
becomes the total household size and this is used to
estimate per capita ATP and per capita health-care pay-
ments. Deaton and Zaidi (2002) suggest that, for devel-
oping countries, the value of h should be between 0.75
and 1.0 while the value of a should lie between 0.3 and
0.5. This is because of the relative importance of food in
total consumption, and the limited scope for economies
of scale. So, if a household has 2 children and 2 adults,
and we set a and h to be 0.5 and 0.75, respectively,
then ES ¼ 2:28 meaning that there are about 2.28 equiv-
alent adults in that household even though the total
household size is 4 persons. If income is used as a
measure of ATP, per adult equivalent income and per
adult equivalent health-care payments are obtained by
dividing total household income and total household
health-care payments by the value of ES for each
household.
Thus, FIA should not necessarily be an end but a means to an end—
that is ensuring equity in the entire health system. FIA results, com-
bined with a detailed BIA can be used to inform policy towards
ensuring UHC. One way to use the results is to reassess overall pro-
gressivity in health financing for a country and to reduce reliance on
regressive financing mechanisms. For example, if OOP spending
comprises 50% of a country’s total health financing and it is esti-
mated as a regressive financing mechanism, a reduction in this share
is likely to have a ‘positive’ effect on overall progressivity as dis-
cussed in Table 2. This is because the overall Kakwani index is the
weighted sum of the Kakwani indices of each health financing
mechanism.
As noted earlier, the availability of quality household survey
data remains a sine qua non for a good FIA. The data should con-
tain information on a cardinal measure of ATP, and information
relevant for extracting each household’s contribution towards
most, if not all, the health financing mechanisms. Unfortunately,
many LMICs face the challenge of poor quality household survey
data or the absence of routine data for the assessment of FIA.
When data for estimating contributions via any health financing
mechanism are not comprehensive, the analyst needs to recognize
this and note its impact on the FIA results. For example, contribu-
tions towards social health insurance may come from both the
employer and the employee. If a dataset does not contain informa-
tion on the employer’s contribution, assumptions may be used to
estimate this directly from the survey. However, if this is omitted,
its impact on the final results needs to be noted. In a case where
there is a general absence of reliable household survey data,
McIntyre and Kutzin (2016) discuss an interim measure to provide
some reasonable approximation of how progressive or regressive
each mechanism may be. In the long term, there will be a need for
countries to invest in the collection of reliable routine data for
monitoring progress towards a progressive and equitable health
financing system. In many cases, there may not be a need for an
entirely ‘new’ survey. A module that will elicit relevant (or missing)
health expenditure and/or ATP variables may be added to an exist-
ing routine household survey. In general, it is important that com-
prehensive household survey data contain enough information as
outlined in Table 2 for conducting FIA.
Routine FIA can be useful not only for assessing progress
towards UHC but also for assessing areas where action is needed for
the country to ensure that the health system is treating households
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fairly. Where necessary, FIA results should inform policy choices
towards a better performing health system.
Note
1. In Stata, -dominance- command written by Owen O’Donnell
can be used to perform statistical dominance tests. http://sitere
sources.worldbank.org/INTPAH/Resources/Publications/4598
43-1195594469249/dominance.ado
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